BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37471616)

  • 1. The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma.
    Rosen BS; Vaishampayan N; Cao Y; Mierzwa ML
    Cancer J; 2023 Jul-Aug 01; 29(4):243-247. PubMed ID: 37471616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
    Abdalla AS; Sheybani ND; Khan SA
    PET Clin; 2022 Apr; 17(2):213-222. PubMed ID: 35256298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
    Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
    Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
    Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
    Arens AI; Troost EG; Schinagl D; Kaanders JH; Oyen WJ
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):521-8. PubMed ID: 22019709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between PET/CT and CT in the staging prior to the treatment of head and neck squamous cell carcinoma.
    García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; McGee-Laso A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
    Braz J Otorhinolaryngol; 2021; 87(1):11-18. PubMed ID: 31337597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
    Lauridsen JK; Rohde M; Thomassen A
    PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
    Sanli Y; Zukotynski K; Mittra E; Chen DL; Nadel H; Niederkohr RD; Subramaniam RM
    Clin Nucl Med; 2018 Dec; 43(12):e439-e452. PubMed ID: 30394934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography in head and neck squamous cell carcinomas].
    Conessa C; Clément P; Foehrenbach H; Poncet JL
    Ann Otolaryngol Chir Cervicofac; 2006 Nov; 123(5):227-39. PubMed ID: 17185920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
    Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
    Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
    Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
    Terada H; Shimode Y; Furukawa M; Sato Y; Hanai N
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922457
    [No Abstract]   [Full Text] [Related]  

  • 18.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
    Adams G; Porceddu SV; Pryor DI; Panizza B; Foote M; Rowan A; Burmeister B
    Head Neck; 2014 Aug; 36(8):1200-6. PubMed ID: 23893554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.